$14.03
-0.23-1.65%
Pre-Market: 5:37 PM EDT
15 minutes delayed
Pacira BioSciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Pacira BioSciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-30 | $0.89 | $0.70 | 27.1 % |
Mar 2024 | 2024-05-07 | $0.62 | $0.62 | 0.00 % |
Dec 2023 | 2024-02-29 | $0.89 | $0.88 | 1.14 % |
Sep 2023 | 2023-11-02 | $0.72 | $0.79 | -8.86 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-30 | $178.02M | $172.48M | 3.21 % |
Mar 2024 | 2024-05-07 | $167.12M | $165.35M | 1.07 % |
Dec 2023 | 2024-02-29 | $181.24M | $181.66M | -0.23 % |
Sep 2023 | 2023-11-02 | $163.93M | $173.00M | -5.25 % |
Pacira BioSciences (PCRX) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on July 30, 2024 for Q2.
The Actual EPS was $0.89, which beat the estimate of $0.70.
The Actual Revenue was $178M, which beat the estimate of $172.5M.
Browse earnings estimates, EPS, and revenue on all stocks.